Showing results (11-20 of 68) with videos related to

Sort By:
Pageof 7
Journal of Cachexia, Sarcopenia and Muscle|August 8, 2019
Sarcopenia and ovarian cancer survival: a systematic review and meta-analysisJorne Ubachs, Janine Ziemons, Iris J G Minis-Rutten, et al.
Gynecologic Oncology|October 5, 2014
Somatic copy number alterations predict response to platinum therapy in epithelial ovarian cancerEvelyn Despierre, Matthieu Moisse, Betül Yesilyurt, et al.
Gynecologic Oncology|July 13, 2021
The effectiveness of monotherapy with PI3K/AKT/mTOR pathway inhibitors in ovarian cancer: A meta-analysisPhyllis van der Ploeg, Aniek Uittenboogaard, Anna M J Thijs, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|February 22, 2014
Epithelial ovarian cancer: rationale for changing the one-fits-all standard treatment regimen to subtype-specific treatmentEvelyn Despierre, Betül T Yesilyurt, Sandrina Lambrechts, et al.
Molecular Cancer|March 25, 2014
Ambivalent role of pFAK-Y397 in serous ovarian cancer--a study of the OVCAD consortiumStefanie Aust, Katharina Auer, Anna Bachmayr-Heyda, et al.
Gynecologic Oncology|February 6, 2022
Signal transduction pathway activity in high-grade serous carcinoma, its precursors and Fallopian tube epitheliumPhyllis van der Ploeg, Aniek Uittenboogaard, Steven L Bosch, et al.
Journal of Ovarian Research|July 2, 2013
Treatment reality in elderly patients with advanced ovarian cancer: a prospective analysis of the OVCAD consortiumFabian Trillsch, Linn Woelber, Christine Eulenburg, et al.
European Journal of Cancer (Oxford, England : 1990)|December 24, 2015
Genetic heterogeneity after first-line chemotherapy in high-grade serous ovarian cancerSandrina Lambrechts, Dominiek Smeets, Matthieu Moisse, et al.
Oncotarget|January 2, 2018
Circulating tumor cells: potential markers of minimal residual disease in ovarian cancer? a study of the OVCAD consortiumEva Obermayr, Natalia Bednarz-Knoll, Beatrice Orsetti, et al.
Plos One|December 3, 2015
Intra-Gene DNA Methylation Variability Is a Clinically Independent Prognostic Marker in Women's CancersThomas E Bartlett, Allison Jones, Ellen L Goode, et al.
Pageof 7